Excluding certain items, Merck’s adjusted earnings per share were $1.40 for the period. That includes a 52-cent impact of charges related to Merck’sacquisitionof cancer drug developer Imago BioSciences last year. The Rahway, New Jersey-based company increased its 2023 sales forecast to $57.7...
Merck on Thursday soundly beat Wall Street profit and revenue forecasts, reporting earnings of $2.14 per share on $15.9 billion in revenue. The company raised its 2022 earnings guidance to between $7.24 and $7.36 per share on $56.9 billion to $58.1 billion in revenue. It previously projected ...
Our Q1 2024 earnings report Merck’s (NYSE: MRK) Q1 2024 results reflect continued strong growth in oncology and vaccines. Our company announced Q1 worldwide sales of $15.8 billion, an increase of 9% from Q1 2023. “Merck has begun 2024 with continuing momentum in our business. We are ha...
Q1 Quarterly statement (PDF) Webcast Earnings Presentation Financial Statement (XLS) Financial Statement (PDF) Regional Sector Sales (XLS) Press Release Summary Financial and Sustainability Reports 2023 Q4 FY 2023 Online Report Annual Report (PDF) Single Entity Report Merck KGaA Online Sustainability...
Our Q1 2024 earnings report Merck’s (NYSE: MRK) Q1 2024 results reflect continued strong growth in oncology and vaccines. Our company announced Q1 worldwide sales of $15.8 billion, an increase of 9% from Q1 2023. “Merck has begun 2024 with continuing momentum in our business. We are ha...
Financial results of fiscal 2023 Net sales decrease organically by 1.6% to € 21.0 billion EBITDA pre down organically by 9.0% to € 5.9 billion “Transitional year” 2023 characterized by demanding market conditions in Life Science and Semiconductor Materials Strong sales and earnings performance of...
Merck KGaA (MKGAF) Q1 2024 Earnings Call TranscriptSA TranscriptsWed, May 15 Merck KGaA (MKGAF) Q4 2023 Earnings Call TranscriptSA TranscriptsThu, Mar. 07 Merck KGaA (MKGAF) Q3 2023 Earnings Call TranscriptSA TranscriptsThu, Nov. 09, 2023 See All Transcripts » ...
Q4 2022Q1 2023Q2 2023Q3 2023Q4 2023Q1 2024Q2 2024Q3 2024 财政期报告日期每股收益营收 2024年3季度 2024-11-14 - - 5.266 B -70.271 M 2024年2季度 2024-08-01 - - 5.352 B +103.9 M 2024年1季度 2024-05-15 - - 5.12 B -23.967 M 2023年4季度 2024-03-07 - - 5.225 B -23.046 M 2023...
Q1 Quarterly statement (PDF) Webcast Earnings Presentation Financial Statement (XLS) Financial Statement (PDF) Regional Sector Sales (XLS) Press Release Summary Financial and Sustainability Reports 2023 Q4 FY 2023 Online Report Annual Report (PDF) Single Entity Report Merck KGaA, Darmstadt, Germany...
Current Price $462.10 NASDAQ: ILMN Illumina Market Cap $22B Current Price $141.09 NASDAQ: GILD Gilead Sciences Market Cap $115B Current Price $92.13 NASDAQ: EXEL Exelixis Market Cap $10B Current Price $35.82 Premium Investing Services Invest better with The Motley Fool. Get stock recommendations,...